NO20053271L - 8-trialkylsiloksy-2,3-dimetyl-9-fenyl-7-okso-7,8,9,10-tetrahydro-imidazo[1,2h]naftyridiner - Google Patents

8-trialkylsiloksy-2,3-dimetyl-9-fenyl-7-okso-7,8,9,10-tetrahydro-imidazo[1,2h]naftyridiner

Info

Publication number
NO20053271L
NO20053271L NO20053271A NO20053271A NO20053271L NO 20053271 L NO20053271 L NO 20053271L NO 20053271 A NO20053271 A NO 20053271A NO 20053271 A NO20053271 A NO 20053271A NO 20053271 L NO20053271 L NO 20053271L
Authority
NO
Norway
Prior art keywords
trialkylsiloxy
naphthyridines
imidazo
tetrahydro
oxo
Prior art date
Application number
NO20053271A
Other languages
English (en)
Norwegian (no)
Inventor
Bernhard Kohl
Jorg Senn-Bilfinger
Jan Koek
Tone Vries
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Publication of NO20053271L publication Critical patent/NO20053271L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO20053271A 2002-12-20 2005-07-04 8-trialkylsiloksy-2,3-dimetyl-9-fenyl-7-okso-7,8,9,10-tetrahydro-imidazo[1,2h]naftyridiner NO20053271L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02028672 2002-12-20
PCT/EP2003/014554 WO2004056362A2 (en) 2002-12-20 2003-12-18 8-trialkysyloxy-2-methyl-9-phenyl-7-0 xo-7,8,9,10- tetrahydroimidazo ‘1,2-h! ‘1,7! naphthyridines

Publications (1)

Publication Number Publication Date
NO20053271L true NO20053271L (no) 2005-07-04

Family

ID=32668731

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20053271A NO20053271L (no) 2002-12-20 2005-07-04 8-trialkylsiloksy-2,3-dimetyl-9-fenyl-7-okso-7,8,9,10-tetrahydro-imidazo[1,2h]naftyridiner

Country Status (16)

Country Link
US (1) US20060041134A1 (pl)
EP (1) EP1585516A2 (pl)
JP (1) JP2006515848A (pl)
KR (1) KR20050088176A (pl)
CN (1) CN1726031A (pl)
AU (1) AU2003293940A1 (pl)
BR (1) BR0316752A (pl)
CA (1) CA2509882A1 (pl)
EA (1) EA010107B1 (pl)
HR (1) HRP20050632A2 (pl)
MX (1) MXPA05006349A (pl)
NO (1) NO20053271L (pl)
PL (1) PL375933A1 (pl)
RS (1) RS20050449A (pl)
WO (1) WO2004056362A2 (pl)
ZA (1) ZA200504045B (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101027277A (zh) * 2004-07-23 2007-08-29 帝斯曼知识产权资产管理有限公司 (2r,3r)－2－羟基－3－氨基－3－芳基－丙酰胺和(2r,3r)－2－羟基－3－氨基－3－芳基－丙酸烷基酯的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0001555A3 (en) * 1997-10-30 2001-01-29 Altana Pharma Ag Tetrahydro-imidazo-naphthyridine derivatives, pharmaceutical compositions thereof and process for their preparation
WO2000017200A1 (en) * 1998-09-23 2000-03-30 Byk Gulden Lomberg Chemische Fabrik Gmbh Tetrahydropyridoethers
WO2001072757A1 (en) * 2000-03-29 2001-10-04 Altana Pharma Ag Tricyclic imidazopyridines
EP1286993B1 (en) * 2000-03-29 2006-06-07 ALTANA Pharma AG Imidazopyridin-8-ones
JP2003528878A (ja) * 2000-03-29 2003-09-30 アルタナ ファルマ アクチエンゲゼルシャフト イミダゾピリジン誘導体のプロドラッグ
CZ20023116A3 (cs) * 2000-03-29 2003-01-15 Altana Pharma Ag Alkylované imidazopyridinové sloučeniny
AU2002210563B2 (en) * 2000-10-25 2007-03-01 Altana Pharma Ag Polysubstituted imidazopyridines as gastric secretion inhibitors
TWI295575B (en) * 2002-04-24 2008-04-11 Altana Pharma Ag Nitrosated imidazopyridines

Also Published As

Publication number Publication date
EA010107B1 (ru) 2008-06-30
CN1726031A (zh) 2006-01-25
WO2004056362A2 (en) 2004-07-08
HRP20050632A2 (hr) 2006-04-30
MXPA05006349A (es) 2005-08-26
CA2509882A1 (en) 2004-07-08
ZA200504045B (en) 2006-07-26
US20060041134A1 (en) 2006-02-23
WO2004056362A3 (en) 2004-09-02
PL375933A1 (pl) 2005-12-12
RS20050449A (sr) 2007-11-15
JP2006515848A (ja) 2006-06-08
AU2003293940A1 (en) 2004-07-14
BR0316752A (pt) 2005-10-25
KR20050088176A (ko) 2005-09-02
EA200500903A1 (ru) 2005-12-29
EP1585516A2 (en) 2005-10-19

Similar Documents

Publication Publication Date Title
MY142807A (en) Benzimidazole derivative and use thereof.
NZ536734A (en) Spiroindolinepiperidine derivatives
WO2006047900A3 (de) Neue topisch anwendbare wirkstoffe gegen mimische und alterabedingt falten
NZ527081A (en) Aniline derivatives useful as phosphodiesterase 4 inhibitors
TW200510381A (en) Novel 2-pyridinecarboxamide derivatives
CA2420576A1 (en) Immunoregulatory compounds, derivatives thereof and their use
MY147730A (en) Metabotropic glutamate receptor antagonists
NO20065184L (no) 1-amino-ftalazinderivater, deres fremstilling og terapeutiske anvendelse derav
NO20071008L (no) Fremgangsmate for fremstilling av N-piperidino-1,5-difenylpyrazol-3-karboksamidderivater
NO20050470L (no) Aminoalkoholderivater
WO2007098608A8 (en) Chiral ligands, their preparation and uses thereof in assymetric reactions
NO20054669L (no) Substituerte kinobenzoxazinanaloger
NO20052074L (no) Substituerte benzoksazinoner og anvendelser derav.
NO20060142L (no) Syklisk tertiaer aminforbindelse
NO20054135L (no) Kipolinon/benzoksazin derivater og anvendelser derav
NO20076000L (no) Aminosyrederivater
NO20074622L (no) Metabolitter for NK-1 antagonister for brekninger
TW200732338A (en) Aromatic compound
NO20071253L (no) Fremgangsmate for syntese av C-2, C-3 substituerte N-alkylerte indoler anvendbare som CPLA2-inhibitorer.
NO20053561L (no) Mettede kinoksalinderivater og deres anvendelse som metabotrofe og glutamatreseptorligander
NO20071754L (no) Biotinylerte heksadekasakkarider, fremstilling og anvendelse derav
DE60235980D1 (de) Cyclische diaminverbindung mit fünfgliedriger cyclischer gruppe
NO20070972L (no) Benzyloksyderivater som MAOB-inhibitorer
JO2433B1 (en) Preparation of heterocyclic lindane landscapes
AR019197A1 (es) COMPUESTOS DERIVADOS DE PIPERIDINA ANTIHISTAMINICOS, COMPUESTOS INTERMEDIOS, PROCEDIMIENTO DE PREPARACIoN DE DERIVADOS DE PIPERIDINA Y PROCEDIMIENTOS DE PREPARACIoN DE INTERMEDIARIOS.

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: PLOUGMANN & VINGTOFT, POSTBOKS 1003 SENTRUM, 0104

FC2A Withdrawal, rejection or dismissal of laid open patent application